U.S. Markets open in 4 hrs 59 mins

What Alexion Pharmaceuticals’ Valuation Trend Indicates

Kenneth Smith
What Alexion Pharmaceuticals’ Valuation Trend Indicates

In September 2018, of the total 18 analysts covering Alexion Pharmaceuticals (ALXN), 16 analysts have given Alexion stock a “buy” or higher rating, and two analysts have given Alexion a “hold” rating. The mean rating for Alexion stock is $1.83 with a target price of $158.41, implying an upside potential of 32.9% over Alexion’s closing price of $119.20 on September 4.